Alluvi BPC 157 TB 500 40mg Pen

Alluvi BPC 157 TB 500 40mg Pen is a dual-peptide research formulation developed for advanced regenerative, tissue-repair, and recovery-focused investigations. This pen-based system combines two extensively studied peptides into a single delivery format, supporting accuracy, consistency, and ease of administration in laboratory research settings.

BPC-157 is widely researched for its role in tissue integrity, angiogenesis, and recovery pathways, while TB-500 is studied for its involvement in cellular migration, actin regulation, and tissue regeneration. Together, these peptides are frequently explored in models focused on repair signaling and structural recovery.

Key Features

• Dual-peptide formulation combining BPC-157 and TB-500

• Total 40mg concentration per pen in Alluvi BPC 157 TB 500 40mg Pen

• Pen-based delivery for controlled dosing

• Designed for regenerative research applications

• Laboratory-grade formulation and stability

How It Works

This formulation supports regenerative research by influencing cellular repair mechanisms and structural signaling pathways. BPC-157 contributes to tissue-support processes, while TB-500 is associated with cellular movement and repair coordination, creating a complementary research profile.

Research Applications

Commonly selected for:

• Regenerative and recovery research

• Tissue-repair signaling studies

• Structural integrity investigations

• Multi-peptide research protocols

Pen-Based Delivery Advantage

The pen system improves dosing accuracy, reduces handling variability, and supports repeatable administration across extended research timelines.

Storage & Quality

Store refrigerated, protect from light, and do not freeze. Intended strictly for research use only.